HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.

Abstract
Histone H3 lysine 9 trimethylation (H3K9me3) is associated with transcriptional repression and regulated by histone lysine methyltransferases such as SUV39H1 and ESET. However, the functional roles of these enzymes in hepatocellular carcinoma (HCC) remain uncertain. In this study, we conducted loss-of-function assays for HCC cells. SUV39H1 knockdown but not ESET knockdown reduced H3K9me3 levels and impaired HCC cell growth and sphere formation. The pharmacological inhibition of SUV39H1 by chaetocin resulted in cell growth inhibition and inducing cellular apoptosis in culture and xenograft subcutaneous tumors. Real-time polymerase chain reaction analysis indicated high levels of SUV39H1 expression in 24 of 42 (57.1%) HCC surgical samples compared with corresponding nontumor tissues. Immunohistochemistry identified high levels of H3K9me3 and ESET proteins in 23 (54.8%) and 29 (69.0%) tumor tissues, respectively. However, these proteins' expressions were only observed in biliary epithelial cells and periportal hepatocytes of nontumor tissues. Expression levels of SUV39H1 but not those of ESET were significantly correlated with H3K9me3 levels. The cumulative HCC recurrence rate was significantly higher for patients with elevated SUV39H1 expression and H3K9me3 levels. In conclusion, our data indicate that elevated SUV39H1 expression and high levels of H3K9me3 have important roles in HCC development and progression. Therefore, the pharmacological inhibition of SUV39H1 may be a promising therapeutic approach for HCC treatment.
AuthorsTetsuhiro Chiba, Tomoko Saito, Kaori Yuki, Yoh Zen, Shuhei Koide, Naoya Kanogawa, Tenyu Motoyama, Sadahisa Ogasawara, Eiichiro Suzuki, Yoshihiko Ooka, Akinobu Tawada, Masayuki Otsuka, Masaru Miyazaki, Atsushi Iwama, Osamu Yokosuka
JournalInternational journal of cancer (Int J Cancer) Vol. 136 Issue 2 Pg. 289-98 (Jan 15 2015) ISSN: 1097-0215 [Electronic] United States
PMID24844570 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2014 UICC.
Chemical References
  • Histones
  • RNA, Messenger
  • RNA, Small Interfering
  • Repressor Proteins
  • SUV39H1 protein, human
  • Methyltransferases
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Apoptosis
  • Blotting, Western
  • Carcinoma, Hepatocellular (enzymology, genetics, mortality, pathology)
  • Cell Cycle
  • Cell Proliferation
  • DNA Methylation
  • Epigenesis, Genetic
  • Female
  • Follow-Up Studies
  • Histones (metabolism)
  • Humans
  • Immunoenzyme Techniques
  • Liver Neoplasms (enzymology, genetics, mortality, pathology)
  • Male
  • Methyltransferases (antagonists & inhibitors, genetics, metabolism)
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Middle Aged
  • Neoplasm Recurrence, Local (enzymology, genetics, mortality, pathology)
  • Promoter Regions, Genetic (genetics)
  • RNA, Messenger (genetics)
  • RNA, Small Interfering (genetics)
  • Real-Time Polymerase Chain Reaction
  • Repressor Proteins (antagonists & inhibitors, genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tumor Cells, Cultured
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: